How long does it take to get results after a sleep study?

Results typically become available within 7-10 business days after testing. The data requires specialized scoring by trained technologists, followed by interpretation by sleep medicine physicians, National Sleep Foundation. Complex cases or studies with unusual findings might require additional time for thorough analysis.

Can someone with anxiety undergo successful sleep testing?

Yes, most people with anxiety complete sleep studies successfully. Technicians receive training to help anxious patients feel comfortable throughout the process. Some healthcare providers prescribe mild anti-anxiety medication specifically for testing situations when necessary.

What happens if no sleep disorder is found?

If diagnostic results don’t reveal a specific sleep disorder, healthcare providers focus on sleep hygiene, behavioral approaches, or environmental modifications. Sometimes normal results indicate that reported symptoms stem from other medical conditions requiring different types of evaluation or treatment.

How often should sleep studies be repeated?

Repeat testing depends on the specific condition and treatment response. Patients with sleep apnea might need repeat studies after significant weight changes, when symptoms return despite treatment, or when switching therapy types. Many people only require one definitive diagnostic study followed by periodic symptom assessments rather than repeat testing.

Can children undergo sleep diagnostic testing?

Yes, children can and sometimes should undergo sleep testing when symptoms indicate potential sleep disorders. Pediatric sleep studies use age-appropriate equipment and interpretation criteria. Children often require specialized testing environments and expertise different from those of adult studies.

What is the most common cause of sleep apnea?

The most common cause is upper airway anatomy — a narrowed pharyngeal space due to factors like excess soft tissue, retrognathia (recessed jaw), or enlarged tonsils. Obesity amplifies this by depositing fat in the parapharyngeal fat pads and reducing lung volume reserve. Most patients have multiple contributing factors rather than a single cause.

Can sleep apnea be caused by being overweight?

Yes. Obesity is the most modifiable risk factor for obstructive sleep apnea. Excess weight narrows the airway through parapharyngeal fat deposition, reduces lung volume reserve (which provides caudal tracheal traction that stabilizes the airway during sleep), and worsens the mechanical load on pharyngeal dilator muscles. Sustained 10% weight loss has been shown to significantly reduce apnea severity.

Is sleep apnea genetic?

There is a genetic component. Craniofacial anatomy — including jaw structure, palate width, and soft tissue dimensions — is substantially heritable. First-degree relatives of patients with sleep apnea have a two- to four-fold higher risk. However, acquired risk factors like weight gain, age-related muscle changes, and behavioral factors also play a major role, meaning genetics is a predisposition rather than a determinant.

Why is sleep apnea more common in men?

Men have a two- to three-fold higher prevalence of sleep apnea than premenopausal women. Contributing factors include a longer pharyngeal airway (more collapsible), greater parapharyngeal fat deposition at the same BMI, and testosterone's effect on upper airway anatomy and ventilatory control. After menopause, the female-male gap narrows significantly, which is attributed partly to the loss of progesterone's respiratory-stimulating effects.

Can sleep apnea go away on its own?

Sleep apnea rarely resolves without intervention. However, it can improve substantially with the right changes. Significant weight loss (10% or more), positional therapy in positional OSA, alcohol and sedative avoidance, and treatment of contributing conditions like hypothyroidism can meaningfully reduce severity. A formal sleep study is necessary to assess whether treatment is still required after lifestyle changes.

Causes Of Sleep Apnea: Risk Factors Explained

Most patients who come in for a sleep evaluation already suspect they have sleep apnea. What they rarely understand is why they have it — and why the patient in the next exam room with the same BMI and the same loud snoring might have a completely different set of contributing factors. Sleep apnea is not a single-cause disease. It is the result of an airway that becomes unstable during sleep for reasons that vary by individual anatomy, body composition, neurological control, and behavior. Understanding the causes matters clinically, because some of them are modifiable and targeting them directly can reduce the severity of sleep apnea and the required treatment intensity.

The Core Mechanism: Why the Upper Airway Collapses During Sleep

Obstructive sleep apnea occurs when the pharyngeal airway — the soft-walled segment of the upper airway extending from the nasopharynx to the larynx — collapses repeatedly during sleep. Unlike the trachea and lower airways, which are held open by cartilaginous rings, the pharynx depends on the active contraction of dilator muscles to maintain patency. During wakefulness, these muscles maintain robust tone. During sleep, particularly in NREM stages N2 and N3 and during REM sleep, that neuromuscular activity drops substantially. In patients with a narrow airway, an unfavorable anatomy, or reduced muscle responsiveness, the drop in tone is enough to allow the airway walls to collapse inward against the respiratory airflow, generating the partial (hypopnea) or complete (apnea) obstruction that defines OSA.

Research over the past two decades has identified four distinct physiological traits that determine whether a given patient develops OSA, and at what severity: upper airway anatomy and collapsibility (how easily the airway closes under negative pressure), pharyngeal dilator muscle responsiveness (how effectively the muscles reopen the airway after partial collapse), the arousal threshold (how easily the brain wakes in response to respiratory disturbance), and loop gain (how aggressively the respiratory control system responds to chemical signals). Each patient has a different combination of these traits, which is why two patients with the same AHI may have very different underlying mechanisms and respond differently to the same treatment.

Anatomical Risk Factors: What the Upper Airway Looks Like in OSA

The size and structure of the bony and soft tissue components of the upper airway are among the strongest determinants of OSA risk. Patients with OSA tend to have a smaller and more collapsible pharyngeal airway than matched controls without OSA, for reasons that relate to both the bony framework and the soft tissue volume within it.

Craniofacial anatomy contributes significantly. Retrognathia — a jaw that sits further posterior than normal — reduces the anteroposterior dimension of the pharyngeal space at the base of the tongue, leaving less room for soft tissue and increasing collapsibility during sleep. A high-arched and narrow hard palate reduces the nasal airway space, increasing nasal resistance and the inspiratory effort that creates negative pressure in the pharynx. Maxillary hypoplasia, as seen in certain craniofacial syndromes, can produce severe OSA in both pediatric and adult patients for the same reason.

Soft tissue enlargement within the pharynx is the other major anatomical pathway. Tonsillar and adenoidal hypertrophy is the dominant cause of OSA in children, and residual tonsillar enlargement contributes to OSA in adults as well. An elongated soft palate, large uvula, or bulky lateral pharyngeal walls reduce the caliber of the velopharyngeal airway. Macroglossia — an enlarged tongue — reduces the oropharyngeal space, and retroposition of the tongue base (glossoptosis) during supine sleep further worsens the obstruction. In patients with positional OSA, the tongue falling posteriorly in the supine position is often the dominant contributor, explaining why sleeping on the side dramatically reduces their event frequency.

A large neck circumference is used clinically as a proxy for the combined effect of anatomical crowding and fat deposition around the pharynx. Neck circumference greater than 17 inches in men and 16 inches in women is an independent predictor of OSA in clinical prediction models.

Obesity, Body Weight, and the Fat-Airway Connection

Obesity is the most prevalent and most modifiable risk factor for obstructive sleep apnea in adults. The mechanisms are multiple and additive. Adipose tissue deposits in the parapharyngeal fat pads — two fatty tissue compartments lateral to the pharynx — physically reduce the lateral airway caliber and increase collapsibility under the negative pressure of inspiration. Fat deposition in the tongue itself increases tongue volume and reduces the tongue’s ability to maintain anterior position during sleep. Truncal obesity raises intra-abdominal pressure, reduces functional residual capacity, and lowers the lung volume reserve that normally helps stabilize the upper airway through caudal traction on the trachea.

The relationship between BMI and AHI is strong but not linear. Among patients with severe obesity (BMI above 40), OSA is nearly universal. Among patients with BMI in the 25–30 range, OSA prevalence is substantially lower but clinically significant, because anatomical and other contributing factors can produce moderate-to-severe disease even in the absence of frank obesity. Conversely, thin patients with significant craniofacial anatomy contributions — particularly retrognathia — can have severe OSA despite normal BMI.

The clinical implication is that weight loss is a high-yield intervention for patients with overweight- or obesity-related OSA. Sustained 10% or greater weight loss has been shown in randomized trials to reduce AHI, lower CPAP pressure requirements, and in some cases produce remission of OSA. The benefit requires maintenance — regain of lost weight is associated with return of OSA to pre-weight-loss severity. Weight-loss interventions should be pursued as adjuncts to primary OSA treatment, with a follow-up sleep study after significant weight change to reassess severity.

Age, Sex, and Hormonal Contributions to Sleep Apnea

OSA prevalence increases substantially with age. In large epidemiological studies, the prevalence of moderate-to-severe OSA (AHI 15 or greater) rises from approximately 10 percent in middle-aged adults to over 25 percent in adults aged 65 and older. The mechanisms relate to the age-associated reduction in pharyngeal dilator muscle tone, increased soft tissue laxity in the pharyngeal walls, and changes in respiratory control that raise loop gain and lower the arousal threshold.

Male sex is a strong independent risk factor for OSA. Men have two to three times higher OSA prevalence than pre-menopausal women of similar age and BMI. The anatomical contribution is significant: men have longer pharyngeal airways, more craniocaudal pharyngeal collapse patterns, and higher pharyngeal fat deposition relative to BMI compared to women. The hormonal contribution is also documented: testosterone promotes upper airway muscle relaxation and central respiratory instability, while progesterone has a mild protective effect on upper airway muscle tone in women.

Menopause substantially increases OSA risk in women. Post-menopausal women have OSA prevalence approaching that of age-matched men, which reflects the loss of progesterone’s protective effect. Hormone replacement therapy is associated with reduced OSA severity in some observational studies, though it is not used clinically as an OSA treatment. The practical implication is that OSA should be actively considered in post-menopausal women presenting with sleep complaints, insomnia, and fatigue — populations in whom the diagnosis is historically underrecognized because of symptom overlap with other post-menopausal conditions.

Hypothyroidism is associated with OSA through multiple mechanisms: weight gain, myxedematous infiltration of upper airway tissues increasing soft tissue bulk, and reduced central respiratory drive. OSA in patients with hypothyroidism may improve substantially with thyroid hormone replacement, though it does not always resolve completely. Thyroid function testing is part of the initial evaluation in appropriate clinical contexts.

Behavioral and Reversible Causes That Worsen OSA

Several behavioral and pharmacological factors worsen OSA and can be modified independently of structural treatment. Alcohol consumed in the hours before sleep reduces pharyngeal dilator muscle tone in a dose-dependent fashion, worsens oxygen desaturation during apnea events, and raises the arousal threshold — meaning the brain requires a more severe desaturation event before waking to restore airway patency. Patients who drink regularly often have meaningfully higher real-world AHI than their in-lab study suggests, because most clinical sleep studies are conducted without alcohol.

Sedative-hypnotic medications — benzodiazepines, non-benzodiazepine GABA-A agonists such as zolpidem and eszopiclone — and opioid analgesics all worsen upper airway obstruction through similar mechanisms: reduced muscle tone and raised arousal threshold. In patients with moderate-to-severe OSA, these medications can substantially worsen nocturnal oxygen desaturation and increase cardiovascular risk. A comprehensive review of all sedating medications is standard at the initial Vector Sleep Diagnostic Center evaluation, and substitution or dose adjustment — where clinically feasible — can improve OSA before primary treatment is even initiated.

Body position is a major OSA modifier in a significant subset of patients. Positional OSA — defined as an AHI in the supine position at least twice the non-supine AHI — affects approximately 50 to 60 percent of OSA patients. In the supine position, the tongue and soft palate fall posteriorly under gravity, reducing the retrolingual and retropalatal airway space. For patients with purely positional OSA and a normal non-supine AHI, positional therapy alone may adequately control the condition. For patients with significant non-supine OSA as well, positional modification reduces the treatment burden but does not replace primary therapy.

Nasal obstruction from allergic rhinitis, nasal polyps, or structural deviation of the nasal septum increases the inspiratory resistance that creates negative pressure in the pharynx during sleep, worsening collapsibility. Treating nasal obstruction — through pharmacological or surgical means — can improve CPAP adherence by reducing required pressure and mask leak, even when it does not resolve OSA independently.

Sleep Apnea Evaluation at Vector Sleep Diagnostic Center in Queens, NY

Dr. Dmitriy Kolesnik, MD, is a board-certified neurologist and sleep medicine specialist who has served as Medical Director of Vector Sleep Diagnostic Center since 2009 and as a Clinical Instructor in Neurology at Weill Cornell Medical College since 2012. The initial evaluation for sleep apnea at Vector includes a structured review of anatomical, anthropometric, and behavioral risk factors — because identifying the dominant contributing causes informs both the diagnostic pathway and the treatment approach. Patients with significant anatomical contributions to their OSA may benefit from a different treatment strategy than patients whose OSA is primarily weight- or position-driven. The full spectrum of sleep apnea treatment options is available, and understanding the long-term risks of untreated sleep apnea is part of every patient’s education at the Rego Park, Queens location.

Key Resources and Entities

Key Entities

Obstructive sleep apnea (Q202387) — a sleep-disordered breathing condition caused by recurrent pharyngeal collapse during sleep; contributing factors include craniofacial anatomy, obesity, age, sex, and behavioral modifiers that are each independently addressable
Pharynx (Q36218) — the soft-walled upper airway segment where OSA obstruction occurs; anatomical caliber, soft tissue volume, and muscle responsiveness of the pharynx determine individual OSA susceptibility
Obesity (Q12174) — the most prevalent and most modifiable OSA risk factor; parapharyngeal fat deposition, tongue hypertrophy, and reduced lung volume reserve each independently worsen airway collapsibility
Polysomnography (Q855091) — the in-lab diagnostic sleep study that characterizes OSA type, positional pattern, severity by AHI and oxygen desaturation, and sleep architecture — essential for identifying the dominant contributing phenotype
Sleep medicine (Q1426307) — the medical specialty that evaluates the multifactorial causes of sleep apnea, integrates diagnostic findings with patient-specific risk factors, and selects the appropriate treatment strategy

Authoritative Resources

NHLBI: What Causes Sleep Apnea — National Heart, Lung, and Blood Institute overview of OSA risk factors including anatomy, weight, age, and sex
Sleep Foundation: Sleep Apnea Causes — evidence-based review of obstructive and central sleep apnea contributing factors with clinical context
UpToDate: OSA Risk Factors — clinical reference covering anatomical, behavioral, and systemic risk factors for obstructive sleep apnea

Topic Overview

Sleep apnea is caused by a combination of anatomical, physiological, and behavioral factors that reduce pharyngeal airway stability during sleep. Craniofacial anatomy — retrognathia, tonsillar hypertrophy, narrow palate — sets the structural baseline. Obesity adds parapharyngeal fat and reduces lung volume reserve. Age reduces dilator muscle tone; male sex and post-menopausal status increase risk through hormonal and anatomical mechanisms. Alcohol, sedative medications, and supine sleep position are reversible modifiers that can be addressed directly. The four OSA phenotypes — anatomy-dominant, muscle responsiveness, arousal threshold, and loop gain variants — explain why identical AHI values can reflect different underlying physiology and respond differently to treatment.

Frequently Asked Questions About Sleep Apnea Causes

What is the main cause of sleep apnea in adults?

In most adults with obstructive sleep apnea, the primary contributing factor is a combination of anatomical predisposition — a pharyngeal airway that is narrower or more collapsible than normal — and reduced pharyngeal dilator muscle tone during sleep. The most common anatomical contributors are obesity-related pharyngeal fat deposition, craniofacial features such as retrognathia or a narrow palate, and soft tissue enlargement including tonsillar hypertrophy and macroglossia. No single cause applies universally; most patients have a primary contributor plus one or more secondary modifiers that worsen the underlying anatomy.

Can sleep apnea develop without being overweight?

Yes. While obesity is the most prevalent modifiable risk factor, OSA is common in patients with normal BMI who have significant craniofacial anatomy contributions — particularly retrognathia, a narrow palate, or significant tonsillar hypertrophy. Thin patients with OSA often have a skeletal or soft tissue explanation that becomes apparent on clinical examination and, when indicated, on drug-induced sleep endoscopy. Conversely, not all patients with obesity develop clinically significant OSA, because the anatomy of the pharyngeal skeleton varies independently of body weight.

Does alcohol cause sleep apnea?

Alcohol does not cause OSA in patients who otherwise have a normal airway, but it substantially worsens existing OSA and can produce apnea events in patients who are borderline by anatomy. Alcohol reduces pharyngeal dilator muscle tone, raises the arousal threshold (requiring deeper desaturation before awakening restores airway patency), and worsens oxygen desaturation during events that do occur. Patients with moderate or severe OSA who drink alcohol in the hours before sleep may have meaningfully higher real-world AHI and worse desaturation than their clinical study suggests.

Why do men get sleep apnea more than women?

Men have two to three times higher OSA prevalence than pre-menopausal women of similar age and BMI for several reasons. Men have longer pharyngeal airways with more craniocaudal collapse patterns. They accumulate more adipose tissue in parapharyngeal fat pads relative to total body fat percentage. Testosterone promotes upper airway muscle relaxation and may worsen central respiratory instability. Progesterone in pre-menopausal women provides a mild protective effect on upper airway muscle tone. After menopause, women’s OSA risk rises substantially and approaches that of age-matched men, reflecting loss of hormonal protection.

Can you develop sleep apnea suddenly?

OSA typically develops gradually as predisposing factors accumulate — weight gain over years, age-related muscle tone reduction, progressive soft tissue changes. However, patients sometimes present as if onset was sudden because the condition was asymptomatic or unrecognized for years before a triggering event brought it to medical attention. A significant weight gain, new medication (particularly sedatives or opioids), menopause, or a medical condition such as hypothyroidism can precipitate a meaningful worsening of borderline or previously subclinical OSA. In rare cases, a neurological event — stroke or brainstem injury — can cause acute-onset central sleep apnea by disrupting respiratory control.

Schedule a Sleep Apnea Evaluation in Queens, NY

Vector Sleep Diagnostic Center evaluates and treats sleep apnea for patients across Queens and the greater New York City area. A clinical evaluation identifies not just whether sleep apnea is present, but which contributing factors are dominant for your specific presentation — information that directly informs treatment selection. Call (718) 830-2800 or schedule an evaluation online to speak with Dr. Kolesnik’s team.